Basic Information
Purevax RCPCh FeLV
Regulatory Information
EMEA/V/C/000085
Authorised
October 11, 2024
Active Substances Detail
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)inactivated feline calicivirosis antigens (FCV 431 and G1 strains)attenuated feline panleucopenia virus (PLI IV)FeLV recombinant canarypox virus (vCP97)attenuated Chlamydophila felis (905 strain)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)
inactivated feline calicivirosis antigens (FCV 431 and G1 strains)
attenuated feline panleucopenia virus (PLI IV)
FeLV recombinant canarypox virus (vCP97)
attenuated Chlamydophila felis (905 strain)
EMA Resources
Detailed Information
Overview Summary
Up-to-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website](https://medicines.health.europa.eu/veterinary/select-language?destination=/node/210934 "(opens in a new window)")